Insider Trading & Ownership of Kush Parmar

Location
San Francisco, CA
Summary
The estimated net worth of Kush Parmar is at least $36,317,693 dollars as of 18 Nov 2025. Kush Parmar is the Director, 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $32.83M. Kush Parmar is the Director, 10%+ Owner of Vor Biopharma Inc. and owns shares of Vor Biopharma Inc. (VOR) stock worth about $3.22M. Kush Parmar is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $241.6K. Kush Parmar is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2K.
Signature
/s/ Kush Parmar
All Insider Reports
All Insider Reports

Notify me when Kush Parmar files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kush Parmar

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRDA Entrada Therapeutics, Inc. Director, 10%+ Owner $32,831,654 -$2,829,187 -7.9% 14 Nov 2025
VOR Vor Biopharma Inc. Director, 10%+ Owner $3,215,274 14 Jun 2022
QTTB Homology Medicines, Inc. Director $241,560 15 Jun 2022
RLYB Rallybio Corp Director $29,205 15 May 2024
AKUS Akouos, Inc. Director, 10%+ Owner 30 Nov 2022

Insider Transactions Reported by Kush Parmar:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.